Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Julien, Viotti"'
Autor:
Emmanuel Chamorey, Eric Francois, Marie-Christine Etienne, Jean-Marc Ferrero, Frederic Peyrade, Emmanuel Barranger, Alexandre Bozec, Rémy Largillier, Ophelie Cassuto, Julien Viotti, Renaud Schiappa, Gérard Milano
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Dihydropyrimidine dehydrogenase (DPD) status is an indicator of a marked risk for toxicity following fluoropyrimidine (FP)-based chemotherapy. This notion is well-established for low DPD status but little is known about the clinic
Externí odkaz:
https://doaj.org/article/cd4f48b432f14f5fbb39a2b8bb2cd237
Autor:
Nicolas Penel, Dominique Vaur, Juliette Thariat, Alexandre Escande, Jennifer le Guevelou, Colin Debaigt, Esma Saada-Bouzid, Julien Viotti, Nazim Khalladi, David Thibouw, Marie Pierre Sunyach, Laurence Moureau-Zabotto, Mohamed Benchalal, Ovidiu Veresezan, Anne Ducassou, Cecile le Pechoux, Maria Jolnerovski, Celine Bazille, Raphael Serre, Christine Lovera
Publikováno v:
BMJ Open, Vol 10, Iss 9 (2020)
Introduction Up to 50% of soft tissue sarcoma (STS) patients develop metastases in the course of their disease. Cytotoxic therapy is a standard treatment in this setting but yields average tumour response rates of 25% at first line and ≤10% at late
Externí odkaz:
https://doaj.org/article/4f03745252c94dfdb17bc3efe4d08e20
Autor:
Julien, Carvelli, Ferhat, Meziani, Jean, Dellamonica, Pierre-Yves, Cordier, Jerome, Allardet-Servent, Megan, Fraisse, Lionel, Velly, Saber Davide, Barbar, Samuel, Lehingue, Christophe, Guervilly, Maxime, Desgrouas, Fabrice, Camou, Christelle, Piperoglou, Frederic, Vely, Olivier, Demaria, Joyson, Karakunnel, Joanna, Fares, Luciana, Batista, Federico, Rotolo, Julien, Viotti, Agnes, Boyer-Chammard, Karine, Lacombe, Erwan, Le Dault, Michel, Carles, Nicolas, Schleinitz, Eric, Vivier, Sarah, Djabarouti
Publikováno v:
Critical Care Medicine
Critical Care Medicine, 2022, 50, pp.1788-1798. ⟨10.1097/ccm.0000000000005683⟩
Critical Care Medicine, 2022, 50, pp.1788-1798. ⟨10.1097/ccm.0000000000005683⟩
International audience; OBJECTIVES: Severe COVID-19 is associated with exaggerated complement activation. We assessed the efficacy and safety of avdoralimab (an anti-C5aR1 mAb) in severe COVID-19. DESIGN: FOR COVID Elimination (FORCE) was a double-bl
Autor:
Laure Santini, Agnès Dupret-Bories, Haitham Mirghani, Aicha Ben Lakdar, Pascal Roger, Guillaume Chambon, Olivier Dassonville, Françoise Chapel, Emmanuel Chamorey, Julien Viotti, Sébastien Vergez, Thibault Galissier, Karen Benezery, Valérie Coste, Benjamin Lallemant, Stéphane Temam, D. Culié, Alexandre Bozec, Nicolas Fakhry, Bruno Guelfucci, Frederic Peyrade, Anne Sophie Ramay, Anne Sudaka, Florence Jourdan-Soulier, P. Gorphe, Alain Bizeau, Gilles Poissonnet, Joanne Guerlain, Renaud Garrel, Esma Saada-Bouzid, A. Modesto, Renaud Schiappa
Publikováno v:
EJSO-European Journal of Surgical Oncology
EJSO-European Journal of Surgical Oncology, WB Saunders, 2021, In press, ⟨10.1016/j.ejso.2020.12.011⟩
EJSO-European Journal of Surgical Oncology, WB Saunders, 2021, In press, ⟨10.1016/j.ejso.2020.12.011⟩
International audience; Background: The aim of this study was to assess the impact of the initial therapeutic strategy on oncologic outcomes in patients with HPV-positive OPSCC.Methods: All p16-positive OPSCCs treated from 2009 to 2014 in 7 centers w
Autor:
Martine Bagot, Youn H. Kim, Pablo L. Ortiz-Romero, Pier Luigi Zinzani, Neha Mehta-Shah, Olivier Dereure, Marie Beylot-Barry, Stéphane Dalle, Eric D Jacobsen, Auris Huen, Andrea Combalia, Maxime Battistella, Alejandro A. Gru, Hélène Moins-Teisserenc, Michael S. Khodadoust, Julien Viotti, Christine Paiva, Marianna Muller, Pierluigi Porcu
Publikováno v:
Blood. 140:3760-3761
Autor:
Gilles Poissonnet, Alexandra Picard-Gauci, Laurent Mortier, Julien Viotti, Julie De Quatrebarbes, Regis Kaphan, Maria Kogay, Henri Montaudié, Caroline Robert, Caroline Dutriaux, Anne-Bénédicte Duval-Modeste, Nicolas Dupin, Stéphane Dalle, Andrea Stefan, Patrick Combemale, Florence Brunet-Possenti, Frederic Peyrade
Publikováno v:
Oncotarget
There is no standard of care for unresectable cutaneous squamous cell carcinoma (cSCC). Chemotherapy, alone or combined with radiotherapy, is commonly used mostly as palliative treatment; moreover, its poor safety profile limits its use most of the t
Autor:
Julien Carvelli, Ferhat Meziani, Jean Dellamonica, Pierre-Yves Cordier, Jerome Allardet-Servent, Megan Fraisse, Lionel Velly, Saber Barbar, Samuel Lehingue, Christophe Guervilly, Maxime Desgrouas, Fabrice Camou, Christelle Piperoglou, Frederic Vely, Robert Zerbib, Emmanuel Mitry, Joyson Karakunnel, Joanna Fares, Luciana Batista, Federico Rotolo, Julien Viotti, Agnès Boyer-Chammard, Sabrina Carpentier, Olivier Demaria, Karine Lacombe, Erwan Le Dault, Nassima Chouaki-Benmansour, michel Carles, Nicolas Schleinitz, Eric Vivier, The Force Study Group
Publikováno v:
SSRN Electronic Journal.
Autor:
B. Hoch, Rémy Largillier, Emmanuel Chamorey, J M Ferrero, C Delaby, Julien Viotti, D. Borchiellini, Ludovic Evesque, Renaud Schiappa, V. Raimondi, C. Hebert, Angélique Saint, Philippe Follana, Jérôme Barrière
Publikováno v:
Supportive Care in Cancer. 28:1639-1647
Anemia is common in oncology and negatively impacts quality of life. However, there is lack of knowledge about iron deficiency (ID) epidemiology. The aim of this study was to prospectively assess iron status in patients with locally advanced or metas
Autor:
Olivier François, Julien Viotti, Arnaud Seigneurin, Bastien Boussat, José Labarère, Patrice Francois, Joris Giai
Publikováno v:
Journal of Patient Safety. 17:e98-e106
Background Case-wise analysis is advocated for the Hospital Survey on Patient Safety culture (HSOPS). Objectives Through a computer-intensive simulation study, we aimed to evaluate the accuracy of various imputation methods in managing missing data i
Autor:
Thibaud Lavrut, Fanny Rocher, Milou-Daniel Drici, Nadège Parassol, Marjorie Bernier, Sarah Line Lancrerot, Julien Viotti
Publikováno v:
Journal of cardiovascular pharmacology. 76(4)
The attractiveness of direct oral anticoagulants (DOACs) over vitamin K antagonists, in addition to a better benefit-risk ratio, stems from the fact that no therapeutic drug monitoring is deemed necessary. This has been recently mitigated by the fact